The ongoing Bundibugyo Ebola outbreak declared in the Democratic Republic of the Congo in May 2026, with rapid cross-border spread to Uganda and isolated detections elsewhere, has shaped trader views on which countries will report cases this year. A WHO public health emergency declaration and lack of approved vaccines or treatments for this strain have intensified focus on regional mobility, surveillance gaps, and response capacity in high-risk neighbors. Ongoing contact tracing, funding surges, and weekly case updates from affected zones could trigger fresh probabilities if new countries confirm infections before year-end, while contained clusters may limit wider listings.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · UpdatedWhich countries will have an Ebola case in 2026?
Which countries will have an Ebola case in 2026?
$32,095 Vol.
Dec 31, 2026
South Sudan
62%
Rwanda
30%
Burundi
27%
United States
22%
Canada
27%
Kenya
50%
India
22%
Republic of the Congo
18%
Nigeria
21%
Ethiopia
49%
Somalia
33%
China
22%
$32,095 Vol.
South Sudan
$1,769 Vol.
62%
Rwanda
$2,128 Vol.
30%
Burundi
$200 Vol.
27%
United States
$9,586 Vol.
22%
Canada
$1,086 Vol.
27%
Kenya
$193 Vol.
50%
India
$732 Vol.
22%
Republic of the Congo
$11,674 Vol.
18%
Nigeria
$25 Vol.
21%
Ethiopia
$65 Vol.
49%
Somalia
$71 Vol.
33%
China
$2,610 Vol.
22%
This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the specified country reported between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.The ongoing Bundibugyo Ebola outbreak declared in the Democratic Republic of the Congo in May 2026, with rapid cross-border spread to Uganda and isolated detections elsewhere, has shaped trader views on which countries will report cases this year. A WHO public health emergency declaration and lack of approved vaccines or treatments for this strain have intensified focus on regional mobility, surveillance gaps, and response capacity in high-risk neighbors. Ongoing contact tracing, funding surges, and weekly case updates from affected zones could trigger fresh probabilities if new countries confirm infections before year-end, while contained clusters may limit wider listings.
This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the specified country reported between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.
Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.
Market Opened: May 22, 2026, 12:35 PM ET
Volume
$32,095End Date
Dec 31, 2026Market Opened
May 22, 2026, 12:35 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the specified country reported between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.The ongoing Bundibugyo Ebola outbreak declared in the Democratic Republic of the Congo in May 2026, with rapid cross-border spread to Uganda and isolated detections elsewhere, has shaped trader views on which countries will report cases this year. A WHO public health emergency declaration and lack of approved vaccines or treatments for this strain have intensified focus on regional mobility, surveillance gaps, and response capacity in high-risk neighbors. Ongoing contact tracing, funding surges, and weekly case updates from affected zones could trigger fresh probabilities if new countries confirm infections before year-end, while contained clusters may limit wider listings.
This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the specified country reported between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.
Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.
Volume
$32,095End Date
Dec 31, 2026Market Opened
May 22, 2026, 12:35 PM ETResolver
0x65070BE91...The ongoing Bundibugyo Ebola outbreak declared in the Democratic Republic of the Congo in May 2026, with rapid cross-border spread to Uganda and isolated detections elsewhere, has shaped trader views on which countries will report cases this year. A WHO public health emergency declaration and lack of approved vaccines or treatments for this strain have intensified focus on regional mobility, surveillance gaps, and response capacity in high-risk neighbors. Ongoing contact tracing, funding surges, and weekly case updates from affected zones could trigger fresh probabilities if new countries confirm infections before year-end, while contained clusters may limit wider listings.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · Updated
Beware of external links.
Beware of external links.
Frequently Asked Questions